Merck to Divest CDMO Business to Lonza
Merck to Divest CDMO Business to Lonza Darmstadt, Germany, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Lonza, a global contract development and manufacturing organization, to acquire the CDMO business of Merck Transaction sharpens the focus of Merck’s Life Science business sector and provides the CDMO business with a strong platform for its next phase of development Life Science sector’s broad portfolio of consumables, technologies and services will continue to equip pharmaceutical, biotechnology and CDMO
Merck to Divest CDMO Business to Lonza Darmstadt, Germany, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Lonza, a global contract development and manufacturing organization, to acquire the CDMO business of Merck Transaction sharpens the focus of Merck’s Life Science business sector and provides the CDMO business with a strong platform for its next phase of development Life Science sector’s broad portfolio of consumables, technologies and services will continue to equip pharmaceutical, biotechnology and CDMO
What's Your Reaction?
